2.2. Design
ADVANCED CANCER
The study is a randomised, double-blind, multicentre, controlled clinical trial of family caregivers of patients with advanced cancer receiving home palliative care, performed at six primary care centres within the Malaga-Guadalhorce Health District, Andalusia, Spain.The present study was approved by the Research Ethics Committee of the Province of Malaga on 28 March 2019 (project code: AP-0157-2018) and was conducted in accordance with the Helsinki Declaration of the World Medical Association. The study was registered with ClinicalTrials.gov, code number NCT04052074, on 9 August 2019, as a form of public accountability. All data used in this project fell within the scope of data protection regulations.